Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules

BACKGROUND: Effective means for early diagnosis are imperative to reduce death rate of non-small cell lung cancer (NSCLC) patients. We aimed to find out high-performance serologic markers to distinguish early-stage NSCLC patients from benign pulmonary nodule patients and healthy controls (HC). Cysta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Yanzhen, Wang, Yu, Wu, Yaxian, Wu, Meng, Xing, Shan, Xie, Ying, Chen, Shulin, Li, Xiaohui, Zhang, Ao, He, Yi, Li, Huilan, Dai, Shuqin, Wang, Junye, Lin, Shudai, Bai, Yunmeng, Du, Hongli, Liu, Wanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168853/
https://www.ncbi.nlm.nih.gov/pubmed/35653624
http://dx.doi.org/10.1177/10732748221104661

Ejemplares similares

Ejemplares similares